Cargando…
Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis
The prognosis of malignant peritoneal mesothelioma is extremely poor with a mean survival time of 12 months. The initial symptoms are poor and atypical. Because of its rare entity and little knowledge of its treatments, there are few reports of long-term survival. We encountered a very unique case w...
Autores principales: | Mitsuka, Yuusuke, Yamazaki, Shintaro, Miyakuni, Taiki, Iwama, Atsuko, Funada, Tomoya, Watanabe, Yoshifumi, Kaiga, Teruo, Okada, Shunji, Kochi, Mitsugu, Takayama, Tadatoshi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929422/ https://www.ncbi.nlm.nih.gov/pubmed/20805950 http://dx.doi.org/10.1159/000318747 |
Ejemplares similares
-
Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy
por: Okada, Shunji, et al.
Publicado: (2017) -
A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report
por: Matsuno, Yoritaka, et al.
Publicado: (2012) -
Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications
por: Shitara, Kohei, et al.
Publicado: (2010) -
The Clinical Importance of the Heterogeneity of HER2 neu
por: Davila, Enrique, et al.
Publicado: (2010) -
Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report
por: Chouffai, Zoubir
Publicado: (2010)